top of page
Search

The need for a low-cost, easy-to-use diagnostic platform to allow the detection infectious diseases


Ron Chiarello PhD, Founder, CEO and Chairman of the Board of Alveo Technologies (NASDAQ: INMB) talks about the need for a low-cost, easy-to-use diagnostic platform to allow more people to detect and manage an infectious disease like COVID-19.


Winning the XPRIZE Rapid COVID-19 Testing Competition has highlighted Alveo's "be.well" diagnostic platform which uses an at-home system to take a nasal swab that gets placed in a disposable cartridge that goes into an analyzer that communicates to a mobile device with RNA-based test results in less than 30 minutes.




Comments


Commenting has been turned off.
bottom of page